Gold(I) <i>N</i>-Heterocyclic Carbene Complexes as Ferroptosis Inducing Anticancer Agents

This study presents the chemical synthesis and biological evaluation of a series of gold(I)-N-heterocyclic carbene complexes as potential anticancer agents. The compounds demonstrated broad activity against various cancer cell lines, exhibiting cytotoxicity in the low micromolar range. Mechanistic investigations revealed that these complexes preferentially accumulate in the mitochondria of cancer cells, where they induce the generation of reactive oxygen species and lipid peroxides, ultimately triggering ferroptosis. Further studies in multicellular tumor spheroids confirmed the compounds' ability to penetrate three-dimensional cellular structures and effectively eradicate them at low micromolar concentrations. This work represents the first known example of a gold(I)-N-heterocyclic carbene complex inducing ferroptosis, expanding the therapeutic potential of gold(I)-based metallodrugs.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2025-04-24
DOI
https://doi.org/10.1021/acsmedchemlett.5c00096
Citations
3
Primary Topic
Ferrocene Chemistry and Applications
Type
article
Field-Weighted Citation Impact
2.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gold(I) N-Heterocyclic Carbene Complexes as Ferroptosis Inducing Anticancer Agents

Stephan A. Hahn, Nicolás Montesdeoca, Johannes Karges, E. Schlegel et al.
3 citations
ACS Medicinal Chemistry Letters
Ferrocene Chemistry and Applications
2.81
article

Gold(I) N-Heterocyclic Carbene Complexes as Ferroptosis Inducing Anticancer Agents

Stephan A. Hahn, Nicolás Montesdeoca, Johannes Karges, E. Schlegel, Thomas Scattolin, Vladislav A. Voloshkin, Steven P. Nolan, Zisis Papadopoulos
article en
3 citations

Abstract

This study presents the chemical synthesis and biological evaluation of a series of gold(I)-N-heterocyclic carbene complexes as potential anticancer agents. The compounds demonstrated broad activity against various cancer cell lines, exhibiting cytotoxicity in the low micromolar range. Mechanistic investigations revealed that these complexes preferentially accumulate in the mitochondria of cancer cells, where they induce the generation of reactive oxygen species and lipid peroxides, ultimately triggering ferroptosis. Further studies in multicellular tumor spheroids confirmed the compounds' ability to penetrate three-dimensional cellular structures and effectively eradicate them at low micromolar concentrations. This work represents the first known example of a gold(I)-N-heterocyclic carbene complex inducing ferroptosis, expanding the therapeutic potential of gold(I)-based metallodrugs.

ACS Medicinal Chemistry LettersVol. 16(5)
University of Padua (IT), Ghent University (BE), Ruhr University Bochum (DE)
Verband der Chemischen Industrie, Fonds der Chemischen Industrie, Fonds Wetenschappelijk Onderzoek, Paul-Ehrlich-Gesellschaft Stiftung, Aventis Foundation, Bijzonder Onderzoeksfonds UGent
Openalex Percentile: Top 11%
Ferrocene Chemistry and Applications
2.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Gold(I) <i>N</i>-Heterocyclic Carbene Complexes as Ferroptosis Inducing Anticancer Agents — Stephan A. Hahn, Nicolás Montesdeoca, et al. · ACS Medicinal Chemistry Letters (2025) | TGRS Research Map | TGRS